This company is no longer active
Salud financiera de hoja de balance de Aerie Pharmaceuticals
Salud financiera controles de criterios 2/6
Información clave
-190.6%
Ratio deuda-patrimonio
US$312.59m
Deuda
| Ratio de cobertura de intereses | n/a |
| Efectivo | US$172.46m |
| Patrimonio | -US$163.98m |
| Total pasivo | US$539.57m |
| Activos totales | US$375.59m |
Actualizaciones recientes sobre salud financiera
No hay actualizaciones
Recent updates
Análisis de la situación financiera
Pasivos a corto plazo: 0P0 has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Pasivo a largo plazo: 0P0 has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Historial y análisis de deuda-patrimonio
Nivel de deuda: 0P0 has negative shareholder equity, which is a more serious situation than a high debt level.
Reducción de la deuda: 0P0's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Hoja de balance
Análisis de cash runway
En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.
Cash runway estable: Whilst unprofitable 0P0 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Pronóstico de cash runway: 0P0 is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 13.9% per year.